IPA | ImmunoPrecise Antibodies Ltd. Annual & Quarterly

Annual Balance Sheets

(In CAD)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	59.98 Million	77.81 Million	93.49 Million	66.95 Million	27.26 Million	28.34 Million
Total Current Assets	11.48 Million	16.79 Million	37.47 Million	48.85 Million	7.69 Million	9.87 Million
Cash And Short Term Investments	3.45 Million	8.28 Million	29.96 Million	41.75 Million	2.6 Million	5.47 Million
Cash and Cash Equivalents	3.45 Million	8.28 Million	29.96 Million	41.75 Million	2.6 Million	5.47 Million
Short Term Investments	-	-	-	-	104.00	-
Net Receivables	4.48 Million	4.41 Million	3.4 Million	4.11 Million	3.74 Million	1.95 Million
Inventory	2.13 Million	2.06 Million	1.61 Million	1.2 Million	818.64 Thousand	2.12 Million
Other Current Assets	1.4 Million	2.57 Million	2.75 Million	2.26 Million	613.99 Thousand	333.7 Thousand
Total Non-Current Assets	48.5 Million	61.02 Million	56.02 Million	18.1 Million	19.56 Million	18.46 Million
Net PPE	17.17 Million	10.72 Million	3.7 Million	4.07 Million	3.16 Million	1.63 Million
Good Will And Intangible Assets	31.24 Million	50.09 Million	52.09 Million	13.83 Million	16.19 Million	16.67 Million
Good Will	7.68 Million	19.17 Million	19.7 Million	7.77 Million	7.9 Million	8.25 Million
Intangible Assets	23.55 Million	30.92 Million	32.39 Million	6.05 Million	8.28 Million	8.41 Million
Long-Term Investments	-	115 Thousand	142 Thousand	111 Thousand	118.89 Thousand	90.4 Thousand
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	86 Thousand	86 Thousand	82 Thousand	79 Thousand	85.12 Thousand	67.45 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	26.06 Million	20.01 Million	18.2 Million	10.03 Million	12.17 Million	10.27 Million
Total Current Liabilities	8.12 Million	5.92 Million	9.26 Million	6.07 Million	7.92 Million	7.2 Million
Account Payables	4.37 Million	3.38 Million	4.76 Million	3.01 Million	1.76 Million	1.59 Million
Tax Payables	553 Thousand	2000.00	451 Thousand	466 Thousand	-	27.26 Thousand
Short Term Debt	1.56 Million	1.11 Million	2.2 Million	986 Thousand	2.87 Million	2.82 Million
Deferred Revenue	1.35 Million	977 Thousand	1.03 Million	1.11 Million	1.47 Million	724.69 Thousand
Other Current Liabilities	837 Thousand	441 Thousand	1.25 Million	964 Thousand	1.81 Million	2.05 Million
Total Non Current Liabilities	17.94 Million	14.09 Million	8.94 Million	3.96 Million	4.24 Million	3.07 Million
Long-Term Debt	12.11 Million	6.15 Million	344 Thousand	2.47 Million	1.63 Million	100.03 Thousand
Deferred Revenue Non Current	-5.82 Million	-	-	1.53 Million	1.51 Million	1.06 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	5.82 Million	278 Thousand	497 Thousand	-1.53 Million	-503 Thousand	-28.71 Thousand
Other Liabilities	-	-	-	-	-	-
Total Equity	33.92 Million	57.8 Million	75.28 Million	56.92 Million	15.08 Million	18.06 Million
Stock Holders Equity	33.92 Million	57.8 Million	75.28 Million	56.92 Million	15.08 Million	18.06 Million
Common Stock	119.77 Million	117.47 Million	114.55 Million	80.1 Million	34.08 Million	32.69 Million
Retained Earnings	-100.26 Million	-73.08 Million	-46.52 Million	-29.81 Million	-22.47 Million	-17.47 Million
Accumulated other comprehensive income	2.02 Million	2.62 Million	-2.47 Million	-687 Thousand	-300.22 Thousand	-228.06 Thousand
Common Stock Equity	33.92 Million	57.8 Million	75.28 Million	56.92 Million	15.08 Million	18.06 Million
Capital Lease Obligation	13.68 Million	7.26 Million	1.23 Million	1.92 Million	1.88 Million	107.07 Thousand
Total Investments	-	115 Thousand	142 Thousand	111 Thousand	119 Thousand	90.4 Thousand
Total Debt	13.68 Million	7.26 Million	2.54 Million	3.45 Million	4.5 Million	2.92 Million
Net Debt	10.22 Million	-1.01 Million	-27.41 Million	-38.3 Million	1.9 Million	-2.54 Million

Breakdown	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2	2023 Q1
Total Assets	59.29 Million	59.98 Million	59.98 Million	78.68 Million	75.6 Million	79.94 Million
Total Current Assets	11.01 Million	11.48 Million	11.48 Million	15.05 Million	15.4 Million	27.08 Million
Cash And Short Term Investments	3.91 Million	3.45 Million	3.45 Million	6.2 Million	6.01 Million	19.24 Million
Cash and Cash Equivalents	3.91 Million	3.45 Million	3.45 Million	6.2 Million	6.01 Million	19.24 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	3.51 Million	4.48 Million	4.48 Million	4.47 Million	5.05 Million	3.72 Million
Inventory	1.86 Million	2.13 Million	2.13 Million	2.53 Million	2.45 Million	1.54 Million
Other Current Assets	1.72 Million	1.4 Million	1.4 Million	2.23 Million	1.88 Million	2.56 Million
Total Non-Current Assets	48.28 Million	48.5 Million	48.5 Million	63.63 Million	60.2 Million	52.85 Million
Net PPE	16.92 Million	17.17 Million	17.17 Million	17.02 Million	12.23 Million	3.47 Million
Good Will And Intangible Assets	31.27 Million	31.24 Million	31.24 Million	46.52 Million	47.87 Million	49.16 Million
Good Will	7.84 Million	7.68 Million	7.68 Million	18.66 Million	18.92 Million	19.01 Million
Intangible Assets	23.42 Million	23.55 Million	23.55 Million	27.85 Million	28.95 Million	30.15 Million
Long-Term Investments	-	-	-	-	-	137 Thousand
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	87 Thousand	86 Thousand	86 Thousand	85 Thousand	87 Thousand	81 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	26.44 Million	26.06 Million	26.06 Million	28.86 Million	23.57 Million	13.7 Million
Total Current Liabilities	11.17 Million	8.12 Million	8.12 Million	9.08 Million	7.53 Million	5.35 Million
Account Payables	4.81 Million	4.37 Million	4.37 Million	4.79 Million	4.11 Million	2.25 Million
Tax Payables	560 Thousand	553 Thousand	553 Thousand	210 Thousand	565 Thousand	123 Thousand
Short Term Debt	4.2 Million	1.56 Million	1.56 Million	1.76 Million	954 Thousand	816 Thousand
Deferred Revenue	1.3 Million	1.35 Million	1.35 Million	2.02 Million	1.61 Million	1.38 Million
Other Current Liabilities	852 Thousand	837 Thousand	837 Thousand	499 Thousand	856 Thousand	902 Thousand
Total Non Current Liabilities	15.27 Million	17.94 Million	17.94 Million	19.78 Million	16.04 Million	8.34 Million
Long-Term Debt	11.89 Million	12.11 Million	12.11 Million	12.62 Million	8.62 Million	308 Thousand
Deferred Revenue Non Current	-3.37 Million	-5.82 Million	-5.82 Million	-6.88 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	3.37 Million	5.82 Million	5.82 Million	7.16 Million	279 Thousand	479 Thousand
Other Liabilities	-	-	-	-	-	-
Total Equity	32.85 Million	33.92 Million	33.92 Million	49.81 Million	52.03 Million	66.24 Million
Stock Holders Equity	32.85 Million	33.92 Million	33.92 Million	49.81 Million	52.03 Million	66.24 Million
Common Stock	120.26 Million	119.77 Million	119.77 Million	118.34 Million	117.47 Million	116.18 Million
Retained Earnings	-102.55 Million	-100.26 Million	-100.26 Million	-82.22 Million	-79.28 Million	-55.9 Million
Accumulated other comprehensive income	2.59 Million	2.02 Million	2.02 Million	1.53 Million	1.92 Million	-4.33 Million
Common Stock Equity	32.85 Million	33.92 Million	33.92 Million	49.81 Million	52.03 Million	66.24 Million
Capital Lease Obligation	13.5 Million	13.68 Million	13.68 Million	14.39 Million	9.57 Million	1.12 Million
Total Investments	-	-	-	-	-	137 Thousand
Total Debt	16.1 Million	13.68 Million	13.68 Million	14.39 Million	9.57 Million	1.12 Million
Net Debt	12.18 Million	10.22 Million	10.22 Million	8.18 Million	3.55 Million	-18.11 Million

Balance Sheet Charts

KITZ Corporation

6498

Full Analysis

Annual Balance Sheets
WiSoL CO.,LTD.

122990

Full Analysis

Annual Balance Sheets
Humble Group AB (publ)

HUMBLE

Full Analysis

Annual Balance Sheets
Menara Ventures Xl - Limited Partnership

MNRA

Full Analysis

Annual Balance Sheets
NEXTIN, Inc.

348210

Full Analysis

Annual Balance Sheets
Kordsa Teknik Tekstil A.S.

KORDS

Full Analysis

Annual Balance Sheets

Global Stocks Search

ImmunoPrecise Antibodies Ltd. (IPA)

Annual Balance Sheets

Balance Sheet Charts

KITZ Corporation

WiSoL CO.,LTD.

Humble Group AB (publ)

Menara Ventures Xl - Limited Partnership

NEXTIN, Inc.

Kordsa Teknik Tekstil A.S.